Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI

During the last decades, the utilization of imaging modalities such as single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI) in every day clinical practice has enabled clinicians to diagnose diseases accurately at early stages. Radiolabeled iron oxide nanoparticles (RIONs) combine their intrinsic magnetic behavior with the extrinsic character of the radionuclide additive, so that they constitute a platform of multifaceted physical properties. Thus, at a practical level, RIONs serve as the physical parent of the so-called dual-modality contrast agents (DMCAs) utilized in SPECT/MRI and PET/MRI applications due to their ability to combine, at real time, the high sensitivity of SPECT or PET together with the high spatial resolution of MRI. This review focuses on the synthesis and in vivo investigation of both biodistribution and imaging efficacy of RIONs as potential SPECT/MRI or PET/MRI DMCAs.

[1]  E. Stiliaris,et al.  99mTc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models , 2022, Nanomaterials.

[2]  Arifudin Achmad,et al.  The Chemical Scaffold of Theranostic Radiopharmaceuticals: Radionuclide, Bifunctional Chelator, and Pharmacokinetics Modifying Linker , 2022, Molecules.

[3]  Jianhua Liu,et al.  ES-MION-Based Dual-Modality PET/MRI Probes for Acidic Tumor Microenvironment Imaging , 2022, ACS omega.

[4]  M. Gazouli,et al.  Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging , 2021, Nanomaterials.

[5]  D. Stamopoulos,et al.  Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles , 2021, Scientific Reports.

[6]  Yan Fang,et al.  Influencing factors and strategies of enhancing nanoparticles into tumors in vivo , 2021, Acta pharmaceutica Sinica. B.

[7]  P. Gawne,et al.  Radiolabelling of nanomaterials for medical imaging and therapy. , 2021, Chemical Society reviews.

[8]  D. Stamopoulos,et al.  Hemocompatibility of gallium-68 labeled iron oxide nanoparticles coated with 2,3-dicarboxypropane-1,1-diphosphonic acid. , 2020, Materials science & engineering. C, Materials for biological applications.

[9]  A. Lahooti,et al.  Development of radiolabeled dextran coated iron oxide nanoparticles with 111-In and its biodistribution studies , 2020 .

[10]  P. Geramifar,et al.  Development of Ga-68 radiolabeled DOTA functionalized and acetylated PAMAM dendrimer-coated iron oxide nanoparticles as PET/MR dual-modal imaging agent , 2020 .

[11]  G. Bormans,et al.  Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe3O4@Al(OH)3 nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution , 2020, EJNMMI Research.

[12]  O. K. Guldu,et al.  89Zr Labeled Fe3O4@TiO2 Nanoparticles: In Vitro Afffinities with Breast and Prostate Cancer Cells. , 2020, Applied organometallic chemistry.

[13]  P. Geramifar,et al.  Development of Ga-68 labeled, biotinylated thiosemicarbazone dextran-coated iron oxide nanoparticles as multimodal PET/MRI probe. , 2020, International journal of biological macromolecules.

[14]  S. Vranješ-Đurić,et al.  99mTc-bisphosphonate-coated magnetic nanoparticles as potential theranostic nanoagent. , 2019, Materials science & engineering. C, Materials for biological applications.

[15]  P. Geramifar,et al.  68Ga-radiolabeled bombesin-conjugated to trimethyl chitosan-coated superparamagnetic nanoparticles for molecular imaging: preparation, characterization and biological evaluation , 2019, International journal of nanomedicine.

[16]  John Kurhanewicz,et al.  Hyperpolarized 13C MRI: State of the Art and Future Directions. , 2019, Radiology.

[17]  Xudong Shi,et al.  Integrin αvβ3 receptor targeting PET/MRI dual-modal imaging probe based on the 64Cu labeled manganese ferrite nanoparticles. , 2018, Journal of inorganic biochemistry.

[18]  A. Harris,et al.  A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis , 2018, Front. Chem..

[19]  M. Brtnický,et al.  Iron Oxide Nanoparticles: Innovative Tool in Cancer Diagnosis and Therapy , 2018, Advanced healthcare materials.

[20]  J. Vanek,et al.  NOTA Complexes with Copper(II) and Divalent Metal Ions: Kinetic and Thermodynamic Studies. , 2018, Inorganic chemistry.

[21]  S. Toma,et al.  Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging , 2018, Pharmaceutical Research.

[22]  M. Gazouli,et al.  Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study , 2017, Contrast media & molecular imaging.

[23]  S. Laurent,et al.  Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications , 2017, Advanced healthcare materials.

[24]  C. Ingvar,et al.  Combined Magnetomotive ultrasound, PET/CT, and MR imaging of 68Ga-labelled superparamagnetic iron oxide nanoparticles in rat sentinel lymph nodes in vivo , 2017, Scientific Reports.

[25]  Heng Zhao,et al.  MR/SPECT Imaging Guided Photothermal Therapy of Tumor-Targeting Fe@Fe3O4 Nanoparticles in Vivo with Low Mononuclear Phagocyte Uptake. , 2016, ACS applied materials & interfaces.

[26]  A. Lahooti,et al.  Development of 177Lu-DTPA-SPIO conjugates for potential use as a dual contrast SPECT/MRI imaging agent , 2016 .

[27]  Dong Soo Lee,et al.  Development of a complementary PET/MR dual-modal imaging probe for targeting prostate-specific membrane antigen (PSMA). , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[28]  P. Geramifar,et al.  PEGylated superparamagnetic iron oxide nanoparticles labeled with 68Ga as a PET/MRI contrast agent: a biodistribution study , 2016, Journal of Radioanalytical and Nuclear Chemistry.

[29]  Christopher Cawthorne,et al.  Chelator free gallium-68 radiolabelling of silica coated iron oxide nanorods via surface interactions. , 2015, Nanoscale.

[30]  D. Abou,et al.  Nuclear molecular imaging with nanoparticles: radiochemistry, applications and translation , 2015, The British journal of radiology.

[31]  M. Mahmoudi,et al.  Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo. , 2015, Contrast media & molecular imaging.

[32]  Zhen Yuan,et al.  PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases. , 2015, Quantitative imaging in medicine and surgery.

[33]  M. Hur,et al.  Synthesis and characterization of 68Ga labeled Fe3O4 nanoparticles for positron emission tomography (PET) and magnetic resonance imaging (MRI) , 2015, Journal of Radioanalytical and Nuclear Chemistry.

[34]  Lu Zhang,et al.  MRI/SPECT/Fluorescent Tri‐Modal Probe for Evaluating the Homing and Therapeutic Efficacy of Transplanted Mesenchymal Stem Cells in a Rat Ischemic Stroke Model , 2015, Advanced functional materials.

[35]  Hossein Afarideh,et al.  Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles. , 2015, Nuclear medicine and biology.

[36]  Bin Zhang,et al.  Radiolabeled cyclic arginine-glycine-aspartic (RGD)-conjugated iron oxide nanoparticles as single-photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) dual-modality agents for imaging of breast cancer , 2015, Journal of Nanoparticle Research.

[37]  George Loudos,et al.  (99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment. , 2014, Journal of colloid and interface science.

[38]  R. Sabaté,et al.  Potential applications of magnetic particles to detect and treat Alzheimer's disease , 2014, Nanoscale Research Letters.

[39]  M. Meyerand,et al.  Intrinsically Germanium‐69‐Labeled Iron Oxide Nanoparticles: Synthesis and In‐Vivo Dual‐Modality PET/MR Imaging , 2014, Advanced materials.

[40]  Hanno Schieferstein,et al.  Radiolabeling of Nanoparticles and Polymers for PET Imaging , 2014, Pharmaceuticals.

[41]  T. Hyeon,et al.  Paramagnetic inorganic nanoparticles as T1 MRI contrast agents. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[42]  Yan Xing,et al.  Radiolabeled Nanoparticles for Multimodality Tumor Imaging , 2014, Theranostics.

[43]  Jan Grimm,et al.  Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle , 2014, Nature Communications.

[44]  Stephen J. Archibald,et al.  Final step gallium-68 radiolabelling of silica-coated iron oxide nanorods as potential PET/MR multimodal imaging agents. , 2014, Faraday discussions.

[45]  Hui Tan,et al.  Design and preliminary assessment of 99mTc-labeled ultrasmall superparamagnetic iron oxide-conjugated bevacizumab for single photon emission computed tomography/magnetic resonance imaging of hepatocellular carcinoma , 2014, Journal of Radioanalytical and Nuclear Chemistry.

[46]  C. Cho,et al.  Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting. , 2013, Biotechnology advances.

[47]  Eun Kyoung Ryu,et al.  Hybrid PET/MR imaging of tumors using an oleanolic acid-conjugated nanoparticle. , 2013, Biomaterials.

[48]  N. P. Ulrih,et al.  Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics. , 2013, Cancer letters.

[49]  In-Kyu Park,et al.  Magnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer , 2013, International journal of molecular sciences.

[50]  Wei Wang,et al.  Carbon-11 radiolabeling of iron-oxide nanoparticles for dual-modality PET/MR imaging. , 2013, Nanoscale.

[51]  Heather M. Hennkens,et al.  Radiometals for combined imaging and therapy. , 2013, Chemical reviews.

[52]  René M. Botnar,et al.  Bisphosphonate-Anchored PEGylation and Radiolabeling of Superparamagnetic Iron Oxide: Long-Circulating Nanoparticles for in Vivo Multimodal (T1 MRI-SPECT) Imaging , 2012, ACS nano.

[53]  Michael S. Hofman,et al.  Is there still a role for SPECT–CT in oncology in the PET–CT era? , 2012, Nature Reviews Clinical Oncology.

[54]  Patrick Couvreur,et al.  Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. , 2012, Chemical reviews.

[55]  D. Meier,et al.  Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[56]  Abass Alavi,et al.  Emerging role of radiolabeled nanoparticles as an effective diagnostic technique , 2012, EJNMMI Research.

[57]  Linda Knutsson,et al.  99mTc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes , 2012, The Journal of Nuclear Medicine.

[58]  Taeghwan Hyeon,et al.  Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. , 2011, Journal of the American Chemical Society.

[59]  G. Glover Overview of functional magnetic resonance imaging. , 2011, Neurosurgery clinics of North America.

[60]  Andrea Protti,et al.  (⁹⁹m)Tc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging. , 2011, Bioconjugate chemistry.

[61]  É. Tóth,et al.  Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies. , 2010, Inorganic chemistry.

[62]  D. Stamopoulos,et al.  On the biocompatibility of Fe3O4 ferromagnetic nanoparticles with human blood cells. , 2010, Journal of nanoscience and nanotechnology.

[63]  Forrest M Kievit,et al.  Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma. , 2010, ACS nano.

[64]  Ambika Bumb,et al.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. , 2010, Chemical reviews.

[65]  J. Zubieta,et al.  Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important radiometals for the molecular imaging era. , 2010, Chemical reviews.

[66]  Kai Chen,et al.  PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.

[67]  Michael J. Welch,et al.  In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent. , 2010, Bioconjugate chemistry.

[68]  Miqin Zhang,et al.  Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. , 2010, Advanced drug delivery reviews.

[69]  T. Yen,et al.  The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles. , 2010, Biomaterials.

[70]  Mark E. Davis,et al.  Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.

[71]  S. Mather,et al.  Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases. , 2009, Chemical communications.

[72]  Mingyuan Gao,et al.  A novel type of dual-modality molecular probe for MR and nuclear imaging of tumor: preparation, characterization and in vivo application. , 2009, Molecular pharmaceutics.

[73]  D. Benaki,et al.  Biocompatibility and Solubility of Fe3O4-BSA Conjugates with Human Blood , 2009 .

[74]  D. Benaki,et al.  Bare and protein-conjugated Fe3O4 ferromagnetic nanoparticles for utilization in magnetically assisted hemodialysis: biocompatibility with human blood cells , 2008, Nanotechnology.

[75]  Jerry S. H. Lee,et al.  Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.

[76]  Chenjie Xu,et al.  PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.

[77]  Pius August Schubiger,et al.  Molecular imaging with PET. , 2008, Chemical reviews.

[78]  Christian Bergemann,et al.  Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. , 2008, Biomaterials.

[79]  Wolfgang A. Weber,et al.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[80]  U. Nielsen,et al.  Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.

[81]  Chao-Ming Fu,et al.  Directly labeling ferrite nanoparticles with Tc-99m radioisotope for diagnostic applications , 2004, IEEE Transactions on Magnetics.

[82]  R. Müller,et al.  A Novel Formulation for Superparamagnetic Iron Oxide (SPIO) Particles Enhancing MR Lymphography: Comparison of Physicochemical Properties and The In Vivo Behaviour , 2002, Journal of drug targeting.

[83]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.